Technology area: Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Golden Diagnostics Corp. has 2 pending office actions in the Chemistry & Materials technology area. These actions involve 2 distinct examiners and are situated within 2 distinct art units. This distribution suggests that the company's chemical innovations are being reviewed by different specialized groups at the USPTO.
GORDON, BRIAN R is the busiest examiner for the company, currently managing 1 pending office action. With 2 distinct examiners each handling one of the 2 pending office actions, the company must navigate multiple examination perspectives. The presence of 2 distinct art units indicates a varied technical scope for the current portfolio.
Practitioners must coordinate responses that are consistent across these different examination groups. The involvement of GORDON, BRIAN R as one of the 2 distinct examiners highlights the need for specialized attention to individual examiner tendencies even in a small portfolio. The presence of 2 pending office actions total indicates an active but manageable volume of ongoing patent prosecution.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GORDON, BRIAN R | 1 | 65.3% | +19.0% |
| HYUN, PAUL SANG HWA | 1 | 69.8% | +36.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 15951659 | Calibration of Fluidic Devices | HYUN, PAUL SANG HWA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18301835 | FLUIDIC MEDICAL DEVICES AND USES THEREOF | GORDON, BRIAN R | — |
| 15951659 | Calibration of Fluidic Devices | HYUN, PAUL SANG HWA | — |
| Art Unit | Apps |
|---|---|
| 1798 | 1 |
| 1796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18301835 | FLUIDIC MEDICAL DEVICES AND USES THEREOF | GORDON, BRIAN R | 1798 | §112DP | Non-Final OA | — | Pending | Apr 17, 2023 |
| 15951659 | Calibration of Fluidic Devices | HYUN, PAUL SANG HWA | 1796 | §103§112 | Non-Final OA | — | Pending | Apr 12, 2018 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGolden Diagnostics Corp. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Brian R Gordon has the most, with 1 of Golden Diagnostics Corp.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
